Linkedin
Sign in
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Type here...
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
Twitter
Subscribe
Subscribe
Saturday, June 6, 2026
28.9
C
Bengaluru
Home
About
Editor’s Corner
Contribute
Contact Us
My account
Get into your account.
Login
Register
type here...
Search
Facebook
Linkedin
Twitter
Youtube
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Vivek V. Kamath Appointed CEO at PlasmaGen BioSciences
0
Picture: Deep Bhandari led session at ACG - MedicinMan...
Navigating India’s Diverging Health Landscape and Field Force Optimisation
0
India’s health map is splitting into two distinct opportunity...
Tariffs and Indian Generics: Is Trump Cutting His Nose to Spite His Face?
0
Trump’s Tariffs Threaten US Drug Affordability The Value of...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
0
India’s caesarean section debate is drifting toward polarisation. On one...
Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?
0
A quiet but revolutionary milestone may be unfolding in...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
0
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
0
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
0
The Anomaly Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
0
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
0
The Two Headlines That Should Not Coexist Two recent news...
Marketing
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
0
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
0
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
0
The Anomaly Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
0
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
0
The Two Headlines That Should Not Coexist Two recent news...
Policies/Sales
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
0
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
0
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
0
The Anomaly Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
0
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
0
The Two Headlines That Should Not Coexist Two recent news...
Strategy
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
0
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
0
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
0
The Anomaly Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
0
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
0
The Two Headlines That Should Not Coexist Two recent news...
Subscribe
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
0
In a landmark decision for India’s biotechnology sector, Kiran...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Cipla’s Leadership Transition from Umang Vohra to Achin Gupta: Succession Planning in Action
0
By Anup Soans | MedicinMan Cipla Limited has announced a...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
0
A Tale of Two Truths: Severance, Up in the...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
0
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
0
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
0
The Anomaly Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
0
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
0
The Two Headlines That Should Not Coexist Two recent news...
Marketing
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
0
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
0
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
0
The Anomaly Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
0
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
0
The Two Headlines That Should Not Coexist Two recent news...
Policies/Sales
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
0
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
0
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
0
The Anomaly Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
0
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
0
The Two Headlines That Should Not Coexist Two recent news...
Strategy
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
0
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
0
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
0
The Anomaly Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
0
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
0
The Two Headlines That Should Not Coexist Two recent news...
Subscribe
Ethics in Healthcare
Exclusive Report
Medical Devices
Ethics in Healthcare
The Tragic Genius of Yellapragada Subbarow
Anup Soans
-
May 28, 2026
Read More
AI in Healthcare
Character: The Ultimate Differentiator in Healthcare and Pharma
Anup Soans
-
May 18, 2026
Read More